Porsha Melcher
Podiatrist · Sugar Land, TXNPI 1437568136
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Paragon 28, Inc. at 30.1% of the total. Reporting peaked in 2022 at $5,693 and has fallen 65.1% since, to $1,984 in 2025.
Across 94 payments — averaging $150.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$4K
- Peerless Surgical Inc.$3K
- Organogenesis Inc.$2K
- Arthrex$2K
- Mimedx Group, Inc.$1K
- Linvatec Corporation$815
- plus $2K from 21 others
What the payments were for
- Travel & lodging$7,87256%
- Food & beverage$3,85527%
- Education$2,40017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 16 | $4,250 |
| Peerless Surgical Inc. | 10 | $2,779 |
| Organogenesis Inc. | 11 | $1,801 |
| Arthrex | 5 | $1,568 |
| Mimedx Group, Inc. | 8 | $1,112 |
| Linvatec Corporation | 3 | $815 |
| Medartis Inc. | 1 | $587 |
| Celularity Inc. | 1 | $267 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $262 |
| Triad Life Sciences Inc. | 3 | $89 |
| Stryker(2 entities) | 3 | $73 |
| Integra Lifesciences Corporation | 4 | $62 |
| Smith+Nephew | 3 | $58 |
| AbbVie(2 entities) | 3 | $54 |
| Merck | 3 | $51 |
| Bioventus LLC | 2 | $50 |
| ERMI LLC | 2 | $42 |
| Globus Medical | 1 | $39 |
| Zimmer Biomet | 1 | $32 |
| Kerecis Limited | 1 | $28 |
| Hartmann USA, Inc. | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Medela LLC | 1 | $13 |
| Wound Management Technologies, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$2,129
- Puraply, NuShield, Affinity$1,655
- APTUS$587
- FOREFOOT$536
- QUANTUM$458
- BioBrace 23mm$458
- NeoSpan$357
- Biovance$267
- Interfyl$267
- UltraMist$267
- Lapidus Nail$117
How this compares
$14,128 in reported general payments places this provider in the 85th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 245 | $11,496 |
| Clotrimazole | 202 | $2,430 |
| Methylprednisolone | 62 | $703 |
| Ammonium Lactate | 19 | $510 |
| Terbinafine Hcl | 34 | $492 |
| Ketoconazole | 48 | $461 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $413 |
| Doxycycline Hyclate | 31 | $268 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $224 |
| Gabapentin | 15 | $98 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Sugar Land
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.